4.6 Article

Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study

Related references

Note: Only part of the references are listed.
Article Veterinary Sciences

Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs

Masato Katayama et al.

Summary: This study aimed to determine whether the therapeutic effect of Mutian on dry and mixed forms of feline infectious peritonitis (FIP) can be predicted using clinical indicators before starting treatment. Physical assessments, viral gene detection, and clinical laboratory tests were performed on cats with mixed FIP and dry FIP before administering Mutian. Significant differences in body temperature, appetite, and activity scores were confirmed between the groups that survived and those that died. Mutian's therapeutic effect was insufficient when total bilirubin levels increased in cats with the mixed form. Neurological clinical signs made it difficult to obtain therapeutic effects in both forms of FIP. The therapeutic effects of Mutian can be predicted based on pre-treatment body temperature, appetite scores, activity scores, and the presence of neurological signs.

VETERINARY SCIENCES (2023)

Article Veterinary Sciences

Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524

Jodie Green et al.

Summary: This study investigates the use of a combination of oral GS-441524 and injectable remdesivir for the treatment of feline infectious peritonitis (FIP) in cats. The results show that 87.5% of cats responded to treatment within 2 days, and 81.3% of cats were alive and in remission at the end of the 12-week treatment period. However, 18.8% of cats died or were euthanized during treatment. These findings suggest that the combination of injectable remdesivir and oral GS-441524 is effective for treating FIP.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2023)

Article Veterinary Sciences

Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524

Sally J. Coggins et al.

Summary: This study aimed to evaluate the efficacy and tolerability of the therapeutic drugs GS-441524 and its prodrug remdesivir (GS-5734) for feline infectious peritonitis (FIP). The results showed that intravenous administration of remdesivir and oral administration of GS-441524 were effective and well-tolerated treatments for FIP. When monitoring treatment efficacy, early emphasis on clinical response and later emphasis on clinicopathologic response appear to be prudent.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2023)

Article Chemistry, Medicinal

Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models

Yingjun Li et al.

Summary: The article reports that the parent nucleoside of remdesivir, GS-441524, shows potent inhibition of SARS-CoV-2 replication and has high efficacy in reducing viral titers in infected organs without notable toxicity in animal studies.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Reproductive Biology

Remdesivir impairs mouse preimplantation embryo development at therapeutic concentrations

Yusuke Marikawa et al.

Summary: In this study, the potential embryotoxicity of remdesivir (RDV) was investigated using mouse preimplantation embryos. The results suggest that RDV has the potential to impair the pluripotent lineage and may have adverse effects on embryonic development.

REPRODUCTIVE TOXICOLOGY (2022)

Article Virology

An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats

Sarah Cook et al.

Summary: Feline infectious peritonitis (FIP) is a fatal disease of cats that currently lacks effective vaccines or treatments. This study aimed to determine and compare the antiviral efficacies of several drugs in vitro and evaluate their pharmacokinetic properties. The results showed that certain drug combinations exhibited synergy against FIPV, the causative agent of FIP.

VIRUSES-BASEL (2022)

Article Virology

Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524

Daniela Krentz et al.

Summary: The study showed that oral treatment with Xraphconn (R) was highly effective for FIP cats, leading to dramatic improvement in clinical and laboratory parameters, massive reduction in viral loads, and without causing serious adverse effects. This drug could be a potential effective treatment option for severe coronavirus-associated diseases in different species.

VIRUSES-BASEL (2021)

Article Agriculture, Dairy & Animal Science

Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis

Sarah Jones et al.

Summary: The study evaluated the use of unlicensed GS-441524-like antiviral therapy in treating cats suspected of FIP. The majority of owners were from the United States, with only a small percentage receiving help from veterinarians. While the treatment cost was high, most owners reported significant improvement within one week, with majority of cats surviving and being cured, despite some relapses and deaths. Reported complications were mainly related to owner administration of injections.

ANIMALS (2021)

Article Infectious Diseases

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Wen-Chien Ko et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Review Public, Environmental & Occupational Health

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses

E. Susan Amirian et al.

ONE HEALTH (2020)

Review Endocrinology & Metabolism

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Awadhesh Kumar Singh et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Veterinary Sciences

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis

Niels C. Pedersen et al.

JOURNAL OF FELINE MEDICINE AND SURGERY (2019)

Review Veterinary Sciences

An update on feline infectious peritonitis: Virology and immunopathogenesis

Niels C. Pedersen

VETERINARY JOURNAL (2014)

Article Veterinary Sciences

Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan

Hsien-Ying Tsai et al.

JOURNAL OF FELINE MEDICINE AND SURGERY (2011)

Article Health Care Sciences & Services

Understanding Equivalence and Noninferiority Testing

Esteban Walker et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2011)

Article Veterinary Sciences

Feline Coronavirus in Multicat Environments

Yvonne Drechsler et al.

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2011)

Review Veterinary Sciences

A review of feline infectious peritonitis virus infection: 1963-2008

Niels C. Pedersen

JOURNAL OF FELINE MEDICINE AND SURGERY (2009)

Article Veterinary Sciences

Pathogenesis of feline enteric coronavirus infection

Niels C. Pedersen et al.

JOURNAL OF FELINE MEDICINE AND SURGERY (2008)

Article Critical Care Medicine

Randomization and allocation concealment: a practical guide for researchers

GS Doig et al.

JOURNAL OF CRITICAL CARE (2005)